B. Riley Wealth Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,316
Closed -$977K 1504
2021
Q2
$977K Sell
5,316
-572
-10% -$98.2K 0.03% 512
2021
Q1
$901K Sell
5,888
-547
-9% -$84.6K 0.03% 509
2020
Q4
$1.01M Sell
6,435
-1,705
-21% -$219K 0.05% 328
2020
Q3
$932K Buy
8,140
+3,017
+59% +$325K 0.05% 325
2020
Q2
$576K Sell
5,123
-363
-7% -$38.5K 0.04% 404
2020
Q1
$493K Buy
5,486
+2,666
+95% +$262K 0.04% 387
2019
Q4
$307K Buy
2,820
+363
+15% +$38.8K 0.03% 587
2019
Q3
$243K Sell
2,457
-1,501
-38% -$169K 0.02% 669
2019
Q2
$520K Buy
3,958
+1,783
+82% +$230K 0.06% 362
2019
Q1
$295K Buy
+2,175
New +$270K 0.04% 503
2018
Q4
Sell
-3,178
Closed -$442K 757
2018
Q3
$442K Sell
3,178
-1
-0% -$125 0.05% 375
2018
Q2
$396K Sell
3,179
-29
-0.9% -$3.39K 0.05% 389
2018
Q1
$359K Sell
3,208
-91
-3% -$10.9K 0.05% 402
2017
Q4
$396K Sell
3,299
-98
-3% -$11.9K 0.05% 368
2017
Q3
$477K Buy
3,397
+52
+2% +$7.07K 0.08% 271
2017
Q2
$407K Buy
3,345
+162
+5% +$18.9K 0.07% 293
2017
Q1
$386K Sell
3,183
-497
-14% -$64.1K 0.08% 282
2016
Q4
$451K Sell
3,680
-390
-10% -$47.7K 0.09% 248
2016
Q3
$499K Sell
4,070
-726
-15% -$93.5K 0.1% 262
2016
Q2
$560K Buy
4,796
+469
+11% +$66.5K 0.11% 222
2016
Q1
$602K Buy
4,327
+329
+8% +$48.3K 0.14% 184
2015
Q4
$764K Buy
3,998
+22
+0.6% +$3.84K 0.15% 173
2015
Q3
$623K Buy
3,976
+200
+5% +$36.5K 0.15% 188
2015
Q2
$685K Buy
3,776
+1,139
+43% +$197K 0.17% 166
2015
Q1
$457K Sell
2,637
-7,947
-75% -$1.44M 0.11% 243
2014
Q4
$5.67K Buy
+10,584
New +$1.96M 0.12% 210
2014
Q3
Sell
-610
Closed -$95.3K 2065
2014
Q2
$95.3K Buy
+610
New +$96.3K 0.02% 748

Other funds holding ALXN